Company intelligence / Profile preview

EveLab Insight

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

EveLab Insight has developed advanced, commercialized platforms for 3D facial mapping and deep learning-based skin analysis. Their systems have been validated through large-scale studies—such as a 431,321-participant wrinkle study—and are used by leading global beauty brands to personalize skincare recommendations and drive R&D innovation. The company’s technology is recognized for its accuracy in quantifying complex skin conditions and supporting evidence-based product development. No clinical drug results apply.

Therapeutic areas: Dermatology
Modalities: AI/Software Diagnostics
Industry: Medical Imaging

Partnerships

DiorShiseido/EFFECTIM

Beyond the preview

Go deeper on EveLab Insight.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EveLab Insight.

Explore the full profile